
Aethlon Medical AEMD
$ 4.45
7.1%
Quarterly report 2025-Q2
added 08-13-2025
Aethlon Medical EV - Enterprise Value 2011-2025 | AEMD
Annual EV - Enterprise Value Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -237 K | -2.78 M | -11.2 M | -8.45 M | 3.6 M | -3.71 M | 11.8 M | 10.8 M | 16.9 M | 34.9 M | 45.5 M | 55.9 M | 25.9 M | 21.2 M | 12.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.9 M | -11.2 M | 14.2 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Dynatronics Corporation
DYNT
|
13.8 M | $ 0.24 | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
89.6 M | $ 1.48 | 1.37 % | $ 20.5 M | ||
|
Natus Medical Incorporated
NTUS
|
863 M | $ 31.08 | 1.94 % | $ 1.05 B | ||
|
Lianluo Smart Limited
LLIT
|
655 M | $ 9.22 | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | $ 3.05 | -5.86 % | $ 30.6 M | ||
|
FONAR Corporation
FONR
|
91.5 M | $ 15.1 | 2.72 % | $ 99 M | ||
|
Cardiovascular Systems
CSII
|
595 M | $ 20.0 | 0.15 % | $ 844 M | ||
|
Neovasc
NVCN
|
639 M | $ 30.03 | - | $ 111 M | ||
|
Apollo Endosurgery
APEN
|
423 M | $ 10.0 | - | $ 475 M | ||
|
Integer Holdings Corporation
ITGR
|
5.99 B | $ 69.02 | 1.11 % | $ 2.32 B | ||
|
Titan Medical
TMDI
|
-20.4 M | $ 0.14 | -26.32 % | $ 19.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
664 M | $ 16.81 | -1.18 % | $ 388 M | ||
|
Pulmonx Corporation
LUNG
|
347 M | $ 1.95 | 1.56 % | $ 76.3 M | ||
|
Medtronic PLC
MDT
|
152 B | $ 92.46 | 0.28 % | $ 119 B | ||
|
Viveve Medical
VIVE
|
1.77 M | $ 0.22 | -15.35 % | $ 1.71 M | ||
|
Invacare Corporation
IVC
|
-34.7 M | $ 0.66 | - | $ 24.7 M | ||
|
Abiomed
ABMD
|
-51.8 M | $ 381.02 | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
696 K | $ 0.55 | 3.58 % | $ 2.21 M | ||
|
Myomo
MYO
|
4.1 M | $ 0.91 | 6.61 % | $ 6.42 M | ||
|
CHF Solutions, Inc.
CHFS
|
-7.7 M | $ 5.28 | 1.15 % | $ 34.5 M | ||
|
CryoLife, Inc.
CRY
|
70.4 M | $ 17.84 | -4.14 % | $ 702 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | $ 24.04 | - | $ 1.77 B | ||
|
Soliton, Inc.
SOLY
|
-100 M | $ 20.12 | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | $ 10.38 | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
427 M | $ 30.65 | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-1.79 M | $ 26.54 | - | $ 462 M | ||
|
Quanterix Corporation
QTRX
|
797 M | $ 5.11 | 3.34 % | $ 192 M | ||
|
AVITA Medical
RCEL
|
290 M | $ 3.96 | 4.91 % | $ 102 M | ||
|
ShockWave Medical
SWAV
|
10.2 B | $ 334.75 | - | $ 12.3 B | ||
|
SeaSpine Holdings Corporation
SPNE
|
385 M | $ 7.16 | 0.28 % | $ 270 M | ||
|
ViewRay
VRAY
|
530 M | $ 2.64 | 1.54 % | $ 468 M | ||
|
Intersect ENT, Inc.
XENT
|
1.02 B | $ 28.24 | - | $ 955 M | ||
|
STRATA Skin Sciences
SSKN
|
59 M | $ 1.68 | 2.44 % | $ 58.3 M | ||
|
Axonics Modulation Technologies
AXNX
|
2.67 B | $ 70.98 | - | $ 3.31 B | ||
|
BIOLASE
BIOL
|
26.8 M | $ 0.13 | -13.19 % | $ 166 K | ||
|
Eargo
EAR
|
-53 M | $ 2.57 | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
350 M | $ 8.61 | -0.35 % | $ 245 M | ||
|
SmileDirectClub
SDC
|
963 M | $ 0.08 | -53.45 % | $ 9.71 M | ||
|
ThermoGenesis Holdings
THMO
|
14 M | $ 0.31 | -25.84 % | $ 171 K | ||
|
Acutus Medical
AFIB
|
40.9 M | $ 0.09 | -26.83 % | $ 2.62 M | ||
|
ClearPoint Neuro
CLPT
|
459 M | $ 16.44 | 3.98 % | $ 444 M | ||
|
Surgalign Holdings
SRGA
|
81.1 M | $ 0.18 | -32.98 % | $ 1.68 M | ||
|
Conformis
CFMS
|
3.84 M | $ 2.27 | - | $ 16.4 M | ||
|
Sientra
SIEN
|
278 M | $ 0.18 | -16.59 % | $ 10.3 M | ||
|
NuVasive
NUVA
|
2.04 B | $ 39.75 | - | $ 2.07 B | ||
|
Cutera
CUTR
|
421 M | $ 0.1 | -10.19 % | $ 1.99 M | ||
|
Nemaura Medical
NMRD
|
40.7 M | $ 0.11 | -17.8 % | $ 2.74 M | ||
|
Vapotherm
VAPO
|
131 M | $ 1.27 | 6.72 % | $ 34 M | ||
|
Globus Medical
GMED
|
11.7 B | $ 86.3 | 2.87 % | $ 11.7 B | ||
|
Viemed Healthcare
VMD
|
386 M | $ 6.39 | 0.31 % | $ 245 M |